Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.24M | 9.26M | 8.93M | 18.62M | 14.36M | 10.77M |
Gross Profit | -3.37M | -2.81M | -949.00K | 1.67M | 2.18M | 1.03M |
EBITDA | -9.77M | -10.81M | -5.74M | -1.36M | 1.71M | 678.63K |
Net Income | -13.37M | -13.65M | -7.34M | -2.46M | 1.14M | 464.98K |
Balance Sheet | ||||||
Total Assets | 9.06M | 11.31M | 14.20M | 20.85M | 11.80M | 11.27M |
Cash, Cash Equivalents and Short-Term Investments | 9.51K | 420.13K | 221.76K | 810.37K | 1.31M | 489.85K |
Total Debt | 10.22M | 10.38M | 8.06M | 6.25M | 136.48K | 88.50K |
Total Liabilities | 26.03M | 25.65M | 20.92M | 20.23M | 10.03M | 10.72M |
Stockholders Equity | -16.97M | -14.34M | -6.72M | 617.45K | 1.77M | 555.69K |
Cash Flow | ||||||
Free Cash Flow | -5.10M | -5.93M | -1.68M | -2.51M | 2.05M | 395.29K |
Operating Cash Flow | -5.10M | -5.93M | -1.68M | -2.45M | 2.07M | 466.21K |
Investing Cash Flow | 323.78K | -40.00K | -437.09K | -269.77K | -1.19M | -216.93K |
Financing Cash Flow | 5.80M | 6.17M | 1.53M | 2.22M | 41.85K | 100.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $17.90B | 11.92 | 10.28% | 3.72% | 9.73% | 1.69% | |
61 Neutral | $24.53M | 2.34 | 12.26% | ― | -9.69% | ― | |
45 Neutral | $16.68M | ― | -58.13% | ― | -80.89% | 50.92% | |
44 Neutral | $2.13M | 0.03 | 108.03% | ― | ― | ― | |
44 Neutral | $19.41M | ― | -1.47% | ― | 34.35% | 93.12% | |
35 Underperform | $12.89M | ― | 220.90% | ― | -98.68% | 91.24% | |
― | $5.51M | 217.02 | 0.14% | 8.82% | ― | ― |
Nature’s Miracle Holding Inc. has recently entered into several settlement agreements to address outstanding financial obligations with various lenders. On July 22, 2025, the company reached a settlement with Funders App LLC regarding a loan dispute, agreeing on a remittance schedule starting July 23, 2025. Additionally, on July 31, 2025, a new payment schedule was agreed upon with Webfunder LLC to settle a merchant cash advance, and on August 1, 2025, a similar agreement was made with Wave Advance, Inc. Furthermore, a Standstill Agreement was reached with MaximCash Solutions LLC on August 6, 2025, following a complaint filed in early July. These agreements reflect the company’s efforts to manage its financial liabilities and may impact its financial stability and relationships with stakeholders.
On August 5, 2025, Nature’s Miracle Holding Inc. entered into a securities purchase agreement with Firstfire Global Opportunities Fund, LLC, which involved the sale of a convertible promissory note and shares of common stock for $150,000. The transaction, closed on August 7, 2025, provided the company with net funding of $144,000, intended for business development and general working capital. This agreement includes restrictions on the company’s ability to issue new securities and grants FirstFire participation rights in future offerings, potentially impacting Nature’s Miracle Holding’s financial strategy and market positioning.
On July 24, 2025, Nature’s Miracle Holding Inc. entered into debt-to-equity conversion agreements with key executives and a noteholder, converting unpaid wages and debt into common stock. This strategic move resulted in an aggregate of 23,520,742 shares outstanding as of July 25, 2025, potentially strengthening the company’s financial position by reducing liabilities and aligning the interests of its executives and stakeholders with the company’s performance.
On July 25, 2025, Nature’s Miracle Holdings Inc. amended its Equity Financing Agreement with GHS Investments, LLC, increasing the maximum purchase amount from $500,000 to $2,000,000 under an equity line of credit up to $20,000,000. This amendment allows the company greater flexibility in raising capital by directing the investor to purchase shares of common stock, potentially impacting its financial operations and market positioning over the next two years.